Loading
CA
Curvebeam AI Limited Stock: price and insider trades · Australia
2 insiders bought €187k of shares over the last 90 days, the latest filed 01 Sept 2026.
Curvebeam AI Limited: what insiders have been doing
Curvebeam AI Limited is a listed company. Its directors and officers file their transactions with ASX. The last twelve months, up to 18 October 2026, brought 8 filings signed by 8 insiders.
Not one open-market sale was filed. On the buying side, 2 insiders reported 2 purchases totalling €187k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 2 senior executives. One trade stands out by size: a purchase of €185k from Gregory Wayne Brown Date of last notice 20 th August 2025 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust, disclosed on 1 September 2026.
Compared with its exchange (2,520 companies, median 2 filings), a count of 8 filings is above the norm. Looking back to 2026, when coverage begins, insiders filed 2 purchases and no sales.
The last insider purchase was made public on 1 September 2026, 47 days ago.
Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Insider Decl.
8
Thresholds
n/a
Buy Volume
€186,947
2 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleArun Bahadur Singh1 buy
Gregory Wayne Brown Date of last notice 20 th August 2025 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust1 buy
Since the insiders bought
- +15.0%Entry A$0.02 · Close 13 Oct 2026 A$0.02
- +55.6%Entry A$0.02 · Close at T+30 A$0.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 22,464 of 24,148 companies
18.6
score / 100
Value1
Quality36
FCF yld-115%
Earn yld-120%
EV/EBITDA·
ROE-60%
Gross mgn46%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended June 2024 · cache
A$0.02
Analyst consensus
Income statement
RevenueA$6.5M
Gross profitA$3M46% margin
EBITDA-A$18.6M-285% margin
Net income-A$23.1M-217.3% margin
Valuation
P/Book0.4x
Beta2.03
Balance sheet & cash
Market capA$19.2M
Total debtA$15.9M
Free Cash Flow-A$22.2M
Debt / Equity64%
Profitability & ownership
ROE-59.9%
ROA-18.7%
% insiders46.2%
% institutions12.1%
Last declaration on 13 October 2026
Declarations8 total
ShareASXISIN AU0000289761ASX:2924-03147784-3A703990
ShareASXISIN AU0000289761ASX:2924-03147707-3A703974
ShareASXISIN AU0000289761ASX:2924-03141323-3A702780
ShareASXISIN AU0000289761ASX:2924-03130333-3A700751
ShareASXISIN AU0000289761ASX:2924-03130166-3A700711
▲
15,000,000 shares@ A$0.02100.0% of flowShareASXISIN AU0000289761ASX:2924-03130162-3A700710
Canonical exit: 30 Nov 2026 (T+90)
20,415 shares@ A$0.1373100.0% of flowShareASXISIN AU0000289761ASX:2924-03122997-3A699183
Canonical exit: 29 Sept 2026 (T+90)
8 of 8 declarations
About Curvebeam AI Limited
Curvebeam AI Limited is a company listed on the XASX, focused on developing artificial intelligence solutions for the healthcare sector.
